• Late - Breaking Abstract Submissions are Now Open!

    2026 Clinical Trials Summit 

  • Thank you for submitting a late-breaking abstract to our Inaugural Clinical Trials Summit!

    Please review the Late - Breaking Abstract Submission guidelines below and if you have any questions, please contact ctsummit@is-gd.org.

    The abstract submission deadline is Oct 1, 2026.

    Use the "Save" button at the end of the form to save your work and return later, if necessary.

  • Submission Information

  • Theme*
  • If accepted, may we include this Late - Breaker Submission in a published collection from the conference?*
  • If accepted, may we include your Late - Breaker Submission in an online gallery of posters from the conference?*
  • Has this work been previously published or presented at a major meeting in the last 12 months?*
  • Full Author List
    Rows

  • Please confirm that all listed authors fulfill the author criteria outlined in ICMJE guidelines:

    1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
    2. Drafting the work or reviewing it critically for important intellectual content; AND
    3. Final approval of the version to be published; AND
    4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Late - Breaking Abstract Submission Content

    Please keep total content to 400 words or less. Note: The title and author list do not count towards the word count of 400 words.  Figures and Tables are welcome.-Upon acceptance, we will inform you of the format of your late breaking submission (e.g. as a poster or oral presentation)

  • Ethical Statement

    Please complete all relevant fields
  • Please confirm that patient privacy is protected and patient data is handled in compliance with relevant regulations and guidelines.*
  • Please confirm that all human subjects research was conducted in alignment with the Declaration of Helsinki.*

  • Please attest to the following statement on author responsibility.

    • The authors of this abstract accept responsibility for the accuracy, integrity, and originality of the work, regardless of technologies used.
    • The authors have carefully reviewed and edited all materials produced through the use of AI.
    • There is no plagiarism of text or images in the work. All quoted material is properly attributed.

  • Disclosure of Interests

    Please complete for presenting author.

  • Please attest to the following statement on author responsibility.

    • The authors of this abstract accept responsibility for the accuracy, integrity, and originality of the work, regardless of technologies used.
    • The authors have carefully reviewed and edited all materials produced through the use of AI.
    • There is no plagiarism of text or images in the work. All quoted material is properly attributed.
  • In item #1 below, report all support for the work reported in this manuscript without time limit.  For all other items, the time frame for disclosure is the past 36 months.*
    Rows
  • Should be Empty: